Patent details

Basic Information

Publication number:

EP2411036

PCT Application Number:

US2010028839

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP107569162

PCT Publication Number:

WO2010111598

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

THYMOSIN BETA4 FOR USE IN TREATING A NEURAL INJURY

French Title of Invention:

THYMOSINE BETA 4 POUR L'UTILISATION DANS LE TRAITEMENT D'UNE BLESSURE DE NEURONES

German Title of Invention:

THYMOSINE BETA4 IN DER VERWENDUNG ZUR BEHANDLUNG VON NEURONALE VERLETZUNG

SPC Number:

Dates

Filing date:

26/03/2010

Grant date:

15/03/2017

EP Publication Date:

01/02/2012

PCT Publication Date:

30/09/2010

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

15/03/2017

EP B1 Publication Date:

15/03/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

26/03/2017

Expiration date:

26/03/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

15/03/2017

 

 

Name:

Henry Ford Health System

Address:

1 Ford Place, Detroit, MI 48202, United States (US)

Inventor

1

Name:

CHOPP, Michael

Address:

United States (US)

2

Name:

ZHANG, Zhenggang

Address:

United States (US)

3

Name:

MORRIS, Daniel C.

Address:

United States (US)

Priority

Priority Number:

163556 P

Priority Date:

26/03/2009

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/24; A61P 25/00; A61P 25/28;

Publication

European Patent Bulletin

Issue number:

201711

Publication date:

15/03/2017

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
13/09/2017	Outgoing Correspondence	1